Hinge Health CFO sells 11,006 shares under plan

Hinge Health, Inc. Chief Financial Officer James Budge reported selling a total of 11,006 shares of Class A Common Stock on March 23, 2026 in three open-market transactions.

Rhea-AI Filing Summary

Hinge Health, Inc. Chief Financial Officer James Budge reported selling a total of 11,006 shares of Class A Common Stock on March 23, 2026 in three open-market transactions. The reported weighted average sale prices were $41.2858, $42.4514 and $42.8023 per share, each with specified intraday price ranges.

These sales were effected under a Rule 10b5-1 trading plan adopted by Budge on June 12, 2025, indicating they were pre-arranged. Following the transactions, he directly owns 401,427 shares of Hinge Health Class A Common Stock.

Insider Trade Summary 10b5-1

Net Seller: 11,006 shares

Net Sell 3 txns

Insider Budge James

Role Chief Financial Officer

Sold 11,006 shs ($465K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	1,988	$41.2858	$82K
Sale	Class A Common Stock	8,346	$42.4514	$354K
Sale	Class A Common Stock	672	$42.8023	$29K

Holdings After Transaction: Class A Common Stock — 401,427 shares (Direct)

Footnotes (4)

1. F1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
2. F2. Represents the weighted average sale price. The lowest price at which shares were sold was $40.73 and the highest price at which shares were sold was $41.69. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
3. F3. Represents the weighted average sale price. The lowest price at which shares were sold was $41.78 and the highest price at which shares were sold was $42.77. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
4. F4. Represents the weighted average sale price. The lowest price at which shares were sold was $42.78 and the highest price at which shares were sold was $42.87. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hinge Health (HNGE) disclose in this Form 4?

Hinge Health (HNGE) disclosed that CFO James Budge sold 11,006 shares of Class A Common Stock on March 23, 2026. The sales occurred in three open-market trades at weighted average prices between roughly $41 and $43 per share.

Were the HNGE CFO’s stock sales made under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected under a Rule 10b5-1 trading plan adopted by James Budge on June 12, 2025. Such plans pre-schedule trades, making the timing more routine and less discretionary from a trading-signal standpoint.

How many Hinge Health (HNGE) shares does the CFO hold after these sales?

After the reported transactions, CFO James Budge directly holds 401,427 shares of Hinge Health Class A Common Stock. This figure reflects his position immediately following the March 23, 2026 open-market sales disclosed in the Form 4 filing.

What prices were received for the Hinge Health (HNGE) shares sold?

The reported weighted average sale prices were $41.2858, $42.4514 and $42.8023 per share. Footnotes explain each figure reflects multiple trades within specified low and high price ranges, with full breakdowns available on request to appropriate parties.

How many separate transactions did the HNGE Form 4 report for the CFO?

The Form 4 reports three separate open-market sale transactions in Hinge Health Class A Common Stock on March 23, 2026. All are coded as “S” for sales and classified as non-derivative transactions involving directly held shares of the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 07:37 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budge James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/23/2026		S(1)		1,988	D	$41.2858(2)	410,445	D
Class A Common Stock	03/23/2026		S(1)		8,346	D	$42.4514(3)	402,099	D
Class A Common Stock	03/23/2026		S(1)		672	D	$42.8023(4)	401,427	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.

2. Represents the weighted average sale price. The lowest price at which shares were sold was $40.73 and the highest price at which shares were sold was $41.69. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

3. Represents the weighted average sale price. The lowest price at which shares were sold was $41.78 and the highest price at which shares were sold was $42.77. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

4. Represents the weighted average sale price. The lowest price at which shares were sold was $42.78 and the highest price at which shares were sold was $42.87. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

	/s/ James Budge	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)